Live feed
Filing
SC 13G/A
SC 13G/A0001274173-24-000071·Oruka Therapeutics, Inc.
Schedule 13G ownership disclosure
ARCA BIOPHARMA INC
Security class unavailable · CUSIP: 00211Y506
Event date: 2024-07-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,482,535
- Percent of class
- 10.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-24-000071
- Form type
- SC 13G/A
- Filer
- Oruka Therapeutics, Inc.
- CIK
- CIK 907654
- Filed
- Jul 05, 2024
- Reporting period
- Jul 02, 2024
- Description
- Schedule 13G beneficial ownership